Brief: Savara Resubmits The Biologics License Application To The U.S. Food And Drug Administration For Molbreevi
22/12/2025 13:51
Dec 22 (Reuters) - Savara Inc SVRA.O: SAVARA RESUBMITS THE BIOLOGICS LICENSE APPLICATION (BLA) TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR MOLBREEVI* FOR THE POTENTIAL TREATMENT OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (AUTOIMMUNE PAP) Source text: ID:nBw6qXjg8a Further company coverage: SVRA.O ((Reuters.Briefs@thomsonreuters.com;))